PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2198
https://www.valueinhealthjournal.com/article/S1098-3015(12)03912-5/fulltext
Section Title :
Cancer
Section Order :
852
First Page :
A438
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03912-5&doi=10.1016/j.jval.2012.08.2198